-
Why Making Dramatic Moves: ServiceSource International (NASDAQ:SREV), Galapagos NV (NASDAQ:GLPG), Fastenal Company (NASDAQ:FAST), TRW Automotive Holdings (NYSE:TRW), Five Prime Therapeutics (NASDAQ:FPRX)
On Friday shares of ServiceSource International, Inc. (NASDAQ:SREV) closed at $4.51. Company’s sales growth for last 5 years was 19.70% and EPS growth for next 5 years is recorded as 25.00%. ServiceSource International Inc. (NASDAQ:SREV) on May 07, reported a loss of $10.2 million in its first quarter. On a per-share basis, the San Francisco-based…
-
Hot Stock List: Histogenics Corporation (NASDAQ:HSGX), FibroGen (NASDAQ:FGEN), Crossroads Systems (NASDAQ:CRDS), BGC Partners (NASDAQ:BGCP), Five Prime Therapeutics (NASDAQ:FPRX)
On Thursday shares of Histogenics Corporation (NASDAQ:HSGX) closed at $7.88. Histogenics Corporation (NASDAQ:HSGX), announced its financial and operational results for the first quarter ended March 31, 2015. For the first quarter of 2015, Histogenics reported a net loss of $(8.0) million, or $(0.60) per share, compared to a net loss of $(3.4) million, or $(5.90)…
-
Big Movers: Five Prime Therapeutics (NASDAQ:FPRX), Xerox Corporation (NYSE:XRX), FuelCell Energy Inc. (NASDAQ:FCEL), Signet Jewelers Limited (NYSE:SIG), Westpac Banking Corporation (NYSE:WBK)
On Wednesday shares of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) closed at $21.00. Five Prime Therapeutics Inc. (NASDAQ:FPRX) on Wednesday reported a loss of $11 million in its first quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 44 cents. The biotech company that develops treatments targeting cancer…
-
Active Stocks: Mylan N.V. (NASDAQ:MYL), Five Prime Therapeutics (NASDAQ:FPRX), Integra LifeSciences Holdings Corporation (NASDAQ:IART), OmegaFlex (NASDAQ:OFLX), Albany Molecular Research Inc. (NASDAQ:AMRI)
On Thursday shares of Mylan N.V. (NASDAQ:MYL) closed at $72.26. Company’s sales growth for last 5 years was 8.70% and EPS growth for next 5 years is recorded as 13.36%. Mylan NV (NASDAQ:MYL) Chairman Robert Coury’s compensation rose 46 percent to $22.5 million in 2014, the drugmaker said Thursday, as it fights off a takeover…
-
Stock Highlights: Five Prime Therapeutics (NASDAQ:FPRX), Morgan Stanley (NYSE:MS), Intel Corporation (NASDAQ:INTC), 21Vianet Group (NASDAQ:VNET), Gastar Exploration Inc. (NYSEMKT:GST)
On Tuesday shares of Five Prime Therapeutics, Inc. (NASDAQ:FPRX) closed at $21.46. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) announced that the company will hold its first Research & Development Day event for the institutional investment community in New York City on May 5, 2015. Morgan Stanley (NYSE:MS) in last trading activity fell -0.03% to close at…
-
Morning Watch List: CareDx, Inc (NASDAQ:CDNA), Five Prime Therapeutics (NASDAQ:FPRX), CatchMark Timber Trust (NYSE:CTT), Intel Corporation (NASDAQ:INTC), First Capital (NASDAQ:FCAP)
On Monday shares of CareDx, Inc (NASDAQ:CDNA) closed at $5.21. On 16 April, CareDx, Inc (NASDAQ:CDNA) announced new evidence that the proportion of cell-free DNA derived from the transplanted organ and found in the bloodstream of the recipient is correlated to the rejection status of the organ. Five Prime Therapeutics, Inc. (NASDAQ:FPRX) in last trading…
-
Stocks to Watch: Mechel OAO (NYSE:MTL), Capnia (NASDAQ:CAPN), Capital One Financial Corporation (NYSE:COF), KeyCorp. (NYSE:KEY), Five Prime Therapeutics (NASDAQ:FPRX), Sparton (NYSE:SPA)
On March 3, Mechel OAO (NYSE:MTL), reports receiving notice from the New York Stock Exchange (NYSE) that Mechel OAO’s American Depositary Receipts (ADRs) are compliant with the listing’s standards requiring that an ADR’s average closing price over 30 consecutive trading days must not be lower than 1 US dollar. On Wednesday shares of Mechel OAO…
-
Top News: Gilead Sciences Inc. (NASDAQ:GILD), Lorillard (NYSE:LO), Five Prime Therapeutics (NASDAQ:FPRX), New York REIT (NYSE:NYRT), J&J Snack Foods (NASDAQ:JJSF)
A $10 version of Sovaldi, the Gilead Sciences Inc. (NASDAQ:GILD) hepatitis C treatment that sells for $1,000 a pill in the U.S., is now available in Bangladesh and could make its way to other parts of the world where the U.S. company doesn’t have patents. On Monday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at…
-
Stocks Gaining Momentum: United States Steel (NYSE:X), Five Prime Therapeutics (NASDAQ:FPRX), Wells Fargo Adv Inc (NYSEMKT:EAD), Tremor Video (NYSE:TRMR), O2Micro International (NASDAQ:OIIM)
United States Steel (NYSE:X) has received a “BB-” credit rating from analysts at Morningstar. The research firm’s “BB-” rating indicates that the company is an above-average default risk. They also gave their stock a four star rating. On Monday shares of United States Steel Corp. (NYSE:X) closed at $24.28. Company’s sales growth for last 5…